Overlap of Familial Mediterranean Fever and Hyper-IgD Syndrome in an Arabic Kindred
- 366 Downloads
Hyperimmunoglobulinemia D Syndrome (HIDS) has rarely been reported in Arabs. Moreover, the simultaneous presence of mutations in MEFV and MVK segregating in the same family is exceptional. We report an Arabic girl presenting since the age of 8-years with two patterns of recurrent episodes of fever, and associated with a spectrum of clinical features suggestive of overlap between familial Mediterranean fever (FMF) and HIDS. Her 19-year old brother presented since the age of 1 year with prolonged episodes of fever and was diagnosed with HIDS at the age of 7 years based on clinical features and homozygosity for p.V377I mutation in MVK. Shorter episodes of fever and abdominal pain more consistent with FMF ensued since the age of 17 years. Genetic testing done for both patients and all other family members revealed simultaneous presence of mutations in MEFV and MVK but with a variable clinical spectrum ranging from asymptomatic to severe manifestations. Both of our patients are homozygous for p.V377I MVK mutation; the girl is a compound heterozygote for p.E148Q/p.P369S/p.R408G and p.E167D/p.F479L MEFV mutations whereas the brother is a compound heterozygote for p.E148Q/p.P369S/p.R408G and p.M680I MEFV mutations. The clinical implications of having more than one mutation in different genes of monogenic autoinflammatory diseases in the same individual are not clear but may explain atypical clinical manifestations such as the overlap features of both FMF and HIDS in this family.
KeywordsAutoinflammatory disorders familial Mediterranean fever hyperimmunoglobulinemia D syndrome
This work is funded in part by Hamad Medical Corporation / Medical research committee approval 13438/13 and 12168/12 (BF) and Qatar National Research Fund (QNRF), Grant # NPRP 09-374-3-092 (HE, RZT)
Nothing to disclose.
- 4.van der Hilst JC, Bodar EJ, Barron KS, Frenkel J, Drenth JP, van der Meer JW, et al. International HIDS Study Group. Long-term follow-up, clinical features, and quality of life in a series of 103 patients with hyperimmunoglobulinemia D syndrome. Medicine (Baltimore). 2008;87:301–10.CrossRefGoogle Scholar
- 8.Dodé C, André M, Bienvenu T, Hausfater P, Pêcheux C, Bienvenu J, et al. French Heraditary Recurrent Inflammatory Disorder Study Group. The enlarging clinical, genetic, and population spectrum of tumor necrosis factor receptor-associated periodic syndrome. Arthritis Rheum. 2002;46(8):2181–8.CrossRefPubMedGoogle Scholar
- 9.Stojanov S, Lohse P, McDermott MF, Renner ED, Kéry A, Mirakian R, et al. Periodic fever due to a novel TNFRSF1A mutation in a heterozygous Chinese carrier of MEFV E148Q. Rheumatology(Oxf). 2004;43:26–7.Google Scholar
- 10.Arkwright PD, McDermott MF, Houten SM, Frenkel J, Waterham HR, Aganna E, et al. Hyper IgD syndrome (HIDS) associated with in vitro evidence of defective monocyte TNFRSF1A shedding and partial response to TNF receptor blockade with etanercept. Clin Exp Immunol. 2002;130:484–8.CrossRefPubMedCentralPubMedGoogle Scholar
- 11.Stojanov S, Lohse P, Lohse P, Hoffmann F, Renner ED, Zellerer S, et al. Molecular analysis of the MVK and TNFRSF1A genes in patients with a clinical presentation typical of the hyperimmunoglobulinemia D with periodic fever syndrome: a low penetrance TNFRSF1A variant in a heterozygous MVK carrier possibly influences the phenotype of hyperimmunoglobulinemia D with periodic fever syndrome or vice versa. Arthritis Rheum. 2004;50:1951–8.CrossRefPubMedGoogle Scholar
- 13.Chandrakasan S, Chwaine S, Adams M, Fathalla BM. Clinical and genetic profile of children with periodic fever syndromes from a Single Medical Centre in South East Michigan. J Clin Immunol. 2013 Nov 15.Google Scholar